国产在线拍偷自揄拍无码,欧美成人精品高清在线观看,又粗又黄又爽视频免费看,亚洲精品一区二区久久

Stock(600222)Hot line:010-61006450

MAH

Leader of "0" Cost MAH 3.0 Era

Platform Overview

Platform Overview
————???????—???????—???????—???????—???????—???????—

 
The project Initiation service platform has more than 20 professional knowledge personnel, all from Shenyang Pharmaceutical University, Chinese Academy of Medical Sciences, Peking Union Medical College and other well-known universities at home and abroad, and has set up generic drug project strategy center, clinical & pharmacology center, intellectual property center, big data analysis center, international new product strategy center, based on the all-round analysis of the pharmaceutical industry and combined with the company's own differentiated positioning, can provide customers with personalized information technology services and comprehensive information assurance.

 Service Content

—???????—???????—???????—???????—???????—???????—???????—???????—???????—

1) Generic Drug Project Initiation: Project development risk assessment is carried out through comprehensive analysis of listed product information, including review overview, patents, market prospects, competition pattern, technical barriers, policy dynamics and other mainstream regulatory countries in Europe, the United States, Japan, China, Canada, Australia and other mainstream regulatory countries.
???????

2)Improvement and Innovation Projects: According to the domestic clinical needs and the guidance of policies and regulations, look for potential improvement and innovation projects, conduct comprehensive research from the aspects of product clinical positioning, market value, competition dynamics, patent layout, and development and listing paths of such projects at home and abroad, determine the adequacy and feasibility of the basis for the topic, and conduct in-depth pharmaceutical technology evaluation, clinical evaluation, development cycle and cost evaluation of the proposed development project.
 

3) Strategy Consulting Service: According to the needs of enterprises, provide partners with product pipeline sustainable development planning, feasibility analysis of new entry fields, and R&D strategy formulation after policy changes, such as the development opportunities and challenges in the cardiovascular field, the key points of improved new drug technology research and development, the analysis of the clinical drug competition pattern of platforms (ophthalmic preparations, enteric-coatedpreparations, sustained-release preparations), and the monthly analysis report of CDE application acceptance products.
 

4)Patent Service: Patent layout of cooperation projects, patent risk assessment of new products, infringement analysis and circumvention strategies, patent search and analysis service, patent tracking and early warning analysis.

5)Resource sharing: The leadingpharm information department cooperates with many well-known pharmaceutical databases at home and abroad (cortellis, intranet, insight, wisdombud), which can provide domestic and foreign listing information, the latest information on industry policies, new products/targets at home and abroad, domestic and foreign product sales and forecast data, market access, clinical guidelines and clinical front-line drug consultation, etc.


 

 

 

 

 

 

 

美女脱了内裤打开腿让男人戳| 国产乱人伦中文无无码视频试看| 人妻少妇精品无码专区漫画| 亚洲一日韩欧美中文字幕在线| 天天躁日日躁aaaaxxxx| 丰满少妇高潮惨叫正在播| 色情推油按摩g点高潮无码视频 | 在教室伦流澡到高潮h免费视频| 中文字幕 一区二区三区| 日本真人大尺度做爰| 超清中文乱码字幕在线观看| 亚洲中文字幕无码爆乳av| 女人下边被添全过程a片小说| 爆乳邻居肉欲中文字幕| 在合欢椅上高潮h| 精品国产黑色丝袜高跟鞋| 灌牛奶cao哭男男腐纯肉打屁股 | 国内精品久久毛片一区二区| 久久久久无码精品国产| 一个人看www在线视频| 精品人伦一区二区三区蜜桃免费| 客厅丝袜麻麻被进进出出| 我的漂亮女房东完整版在线韩剧| 欧美孕妇变态重口另类| 俄罗斯丰满熟妇hd| 精品久久人人妻人人做精品| 最近2019中文字幕电影免费看| 国产乱人对白a片麻豆| 激情的丝袜麻麻| 护士长在办公室躁bd| 啦啦啦啦WWW视频免费观看| 无码人妻一区二区三区免费看| 免费成人在线视频| 久久久久性色AV毛片特级| 鬼父在线视频观看| 人妻换人妻a片爽麻豆| 久久无码人妻一区二区三区| 亚洲国产精品成人综合色在线| 天天躁日日躁狠狠躁视频2021| 两个体校校草被c出水| 熟妇人妻av无码一区二区三区|